Literature DB >> 21746929

Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.

Lea Barfod1, Michael B Dalgaard, Suzan T Pleman, Michael F Ofori, Richard J Pleass, Lars Hviid.   

Abstract

Plasmodium falciparum malaria is a major cause of mortality and severe morbidity. Its virulence is related to the parasite's ability to evade host immunity through clonal antigenic variation and tissue-specific adhesion of infected erythrocytes (IEs). The P. falciparum erythrocyte membrane protein 1 (PfEMP1) family is central to both. Here, we present evidence of a P. falciparum evasion mechanism not previously documented: the masking of PfEMP1-specific IgG epitopes by nonspecific IgM. Nonspecific IgM binding to erythrocytes infected by parasites expressing the PfEMP1 protein VAR2CSA (involved in placental malaria pathogenesis and protective immunity) blocked subsequent specific binding of human monoclonal IgG to the Duffy binding-like (DBL) domains DBL3X and DBL5ε of this PfEMP1 variant. Strikingly, a VAR2CSA-specific monoclonal antibody that binds outside these domains and can inhibit IE adhesion to the specific VAR2CSA receptor chondroitin sulfate A was unaffected. Nonspecific IgM binding protected the parasites from FcγR-dependent phagocytosis of VAR2CSA(+) IEs, but it did not affect IE adhesion to chondroitin sulfate A or lead to C1q deposition on IEs. Taken together, our results indicate that the VAR2CSA affinity for nonspecific IgM has evolved to allow placenta-sequestering P. falciparum to evade acquired protective immunity without compromising VAR2CSA function or increasing IE susceptibility to complement-mediated lysis. Furthermore, functionally important PfEMP1 epitopes not prone to IgM masking are likely to be particularly important targets of acquired protective immunity to P. falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21746929      PMCID: PMC3145728          DOI: 10.1073/pnas.1103708108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin.

Authors:  Niloofar Rasti; Fatuma Namusoke; Arnaud Chêne; Qijun Chen; Trine Staalsoe; Mo-Quen Klinkert; Florence Mirembe; Fred Kironde; Mats Wahlgren
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

Review 2.  Malaria in pregnancy: pathogenesis and immunity.

Authors:  Stephen J Rogerson; Lars Hviid; Patrick E Duffy; Rose F G Leke; Diane W Taylor
Journal:  Lancet Infect Dis       Date:  2007-02       Impact factor: 25.071

3.  The human IgM pentamer is a mushroom-shaped molecule with a flexural bias.

Authors:  Daniel M Czajkowsky; Zhifeng Shao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

Review 4.  The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development.

Authors:  Lars Hviid
Journal:  Hum Vaccin       Date:  2010-01-23

Review 5.  Naturally acquired immunity to Plasmodium falciparum malaria in Africa.

Authors:  Lars Hviid
Journal:  Acta Trop       Date:  2005-09       Impact factor: 3.112

6.  Identification of Plasmodium falciparum var1CSA and var2CSA domains that bind IgM natural antibodies.

Authors:  Jean-Philippe Semblat; Ahmed Raza; Sue A Kyes; J Alexandra Rowe
Journal:  Mol Biochem Parasitol       Date:  2006-01-06       Impact factor: 1.759

7.  Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA.

Authors:  Lea Barfod; Nadia L Bernasconi; Madeleine Dahlbäck; David Jarrossay; Pernille Haste Andersen; Ali Salanti; Michael F Ofori; Louise Turner; Mafalda Resende; Morten A Nielsen; Thor G Theander; Federica Sallusto; Antonio Lanzavecchia; Lars Hviid
Journal:  Mol Microbiol       Date:  2006-12-14       Impact factor: 3.501

8.  Identification of residues in the Cmu4 domain of polymeric IgM essential for interaction with Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

Authors:  Ashfaq Ghumra; Jean-Philippe Semblat; Richard S McIntosh; Ahmed Raza; Ingunn B Rasmussen; Ranveig Braathen; Finn-Eirik Johansen; Inger Sandlie; Patricia K Mongini; J Alexandra Rowe; Richard J Pleass
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

Review 9.  IgM, Fc mu Rs, and malarial immune evasion.

Authors:  Daniel M Czajkowsky; Ali Salanti; Sisse B Ditlev; Zhifeng Shao; Ashfaq Ghumra; J Alexandra Rowe; Richard J Pleass
Journal:  J Immunol       Date:  2010-05-01       Impact factor: 5.422

10.  Human monoclonal IgG selection of Plasmodium falciparum for the expression of placental malaria-specific variant surface antigens.

Authors:  J Soerli; L Barfod; T Lavstsen; N L Bernasconi; A Lanzavecchia; L Hviid
Journal:  Parasite Immunol       Date:  2009-06       Impact factor: 2.280

View more
  44 in total

1.  Functional antibodies against VAR2CSA in nonpregnant populations from colombia exposed to Plasmodium falciparum and Plasmodium vivax.

Authors:  Sedami Gnidehou; Justin Doritchamou; Eliana M Arango; Ana Cabrera; Maria Isabel Arroyo; Kevin C Kain; Nicaise Tuikue Ndam; Amanda Maestre; Stephanie K Yanow
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malaria.

Authors:  Lester H Lambert; Jeanee L Bullock; Sharma T Cook; Kazutoyo Miura; David N Garboczi; Mahamadou Diakite; Rick M Fairhurst; Kavita Singh; Carole A Long
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites.

Authors:  Paulina Ampomah; Liz Stevenson; Michael F Ofori; Lea Barfod; Lars Hviid
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

4.  Production, crystallization and X-ray diffraction analysis of two nanobodies against the Duffy binding-like (DBL) domain DBL6ℇ-FCR3 of the Plasmodium falciparum VAR2CSA protein.

Authors:  Anneleen Vuchelen; Els Pardon; Jan Steyaert; Benoît Gamain; Remy Loris; Nico A J van Nuland; Stéphanie Ramboarina
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-02-22

5.  Submicroscopic infections with Plasmodium falciparum during pregnancy and their association with circulating cytokine, chemokine, and cellular profiles.

Authors:  Samad A Ibitokou; Stéphanie Boström; Laurent Brutus; Nicaise Tuikue Ndam; Bertin Vianou; Carine Agbowaï; Martin Amadoudji Zin; Bich Tram Huynh; Achille Massougbodji; Philippe Deloron; Marita Troye-Blomberg; Nadine Fievet; Adrian J F Luty
Journal:  Clin Vaccine Immunol       Date:  2014-04-09

6.  Role of the VlsE Lipoprotein in Immune Avoidance by the Lyme Disease Spirochete Borrelia burgdorferi.

Authors:  Troy Bankhead
Journal:  For Immunopathol Dis Therap       Date:  2016

Review 7.  Variant surface antigens of Plasmodium falciparum and their roles in severe malaria.

Authors:  Mats Wahlgren; Suchi Goel; Reetesh R Akhouri
Journal:  Nat Rev Microbiol       Date:  2017-06-12       Impact factor: 60.633

8.  Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.

Authors:  Tracy Saveria; Andrew V Oleinikov; Kathryn Wiliamson; Richa Chaturvedi; Joe Lograsso; Gladys J Keitany; Michal Fried; Patrick Duffy
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

Review 9.  Factors influencing phagocytosis of malaria parasites: the story so far.

Authors:  Caroline Lin Lin Chua; Ida May Jen Ng; Bryan Ju Min Yap; Andrew Teo
Journal:  Malar J       Date:  2021-07-16       Impact factor: 2.979

10.  Variable VlsE is critical for host reinfection by the Lyme disease spirochete.

Authors:  Artem S Rogovskyy; Troy Bankhead
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.